Tradestie Institutional Equity Comparison Engine
BMED vs DEUS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DEUS Overall Edge
DEUS Captures Institutional Edge (1โ1 Pillars ยท 2โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xtrackers Russell US Multifactor ETF (DEUS) driven by superior Options & Structure while BMED counters with relative strength in Momentum & Technical. Fundamentally, BMED trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus DEUS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BMED sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against DEUS sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BMED N/M vs DEUS N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
BMED
1Y +26.3% vs +17.9% ยท 52W Pos 86% vs 92%
Options & Structure Winner
DEUS
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (50th %ile IV)
BMED
NYSE Arca
iShares Health Innovation Active ETF
Institutional Equity
$35.93
-1.06% 1D
Market Cap
N/A
1M Return
+3.99%
1Y Return
+26.28%
Forward P/E
N/M
Unified AI Score
51.8 / 100
HOLD
Tech 44.0
Fund 44.0
Flow 50.0
Mom 41.6
DEUS
NYSE Arca
Xtrackers Russell US Multifactor ETF
Institutional Equity
$67.94
-0.56% 1D
Market Cap
N/A
1M Return
+3.04%
1Y Return
+17.91%
Forward P/E
N/M
Unified AI Score
47.3 / 100
HOLD
Tech 40.0
Fund 42.0
Flow 50.0
Mom 41.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BMED +26.28%
DEUS +17.91%
Spread: +5.76 pp (BMED Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BMED TTM Op. Margin: N/A
DEUS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMED vs DEUS. Trailing 12-month operating profitability (BMED N/A vs DEUS N/A) and valuation multiples (BMED N/M vs DEUS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BMED | DEUS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 86% ($27โ$37) | 92% ($56โ$69) | Stronger Trend | DEUS |
| Beta / 30D Volatility Risk Regime | 0.61ฮฒ ยท 24% Vol | 0.50ฮฒ ยท 16% Vol | Lower Realized Risk | DEUS |
| Unified Institutional Score Composite Signal | 51.8 / 100 (HOLD) | 47.3 / 100 (HOLD) | Higher Composite | BMED |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BMED vs DEUS Buy Guide
BMED
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
DEUS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BMED nor DEUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.